Engineered yeast boosts lab production of CBD and CBDA
A study on the directed engineering and multiple transformations of cannabidiolic acid synthase to enhance the expression level of the recombinant enzyme.
AI Summary
Researchers engineered cannabidiolic acid synthase (CBDAS)—the enzyme involved in producing cannabidiolic acid (CBDA)—to work more effectively in yeast. The redesigned enzyme contained several targeted amino-acid changes, and computer modeling suggested that stronger molecular interactions and more contact points with its substrate may explain its improved catalytic activity.
In Pichia pastoris yeast, the engineered strain produced 71.543 ng/mL of CBDA and 75.163 ng/mL of CBD, representing increases of 11.87% and 11.53% over the comparison mutant. A second round of gene transformation further increased CBDA and CBD yields by 9.77% and 12.65%, respectively. Expression worked across a broad range of temperatures and pH levels, with the best results at 30°C and pH 6. These findings support future laboratory-scale, enzyme-based production of CBD, but they do not show effects in cannabis users or clinical benefits.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.